Author: Kathy Whitney
Feb. 4, 2016—The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease’s slow progression.
Jan. 14, 2016—Björn Knollmann, M.D., Ph.D., has been named director of the newly formed Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART).
Nov. 19, 2015—At 6 feet 4 inches, Shea Weber towers over the tiny tots he visits at Monroe Carell Jr. Children’s Hospital at Vanderbilt, yet it is he who looks up to them.
Nov. 5, 2015—People with high fitness levels in midlife have significantly lower annual health care costs after age 65 than people with low fitness in midlife, after adjusting for cardiovascular risk factors, according to a study published in the Journal of the American College of Cardiology (JACC).
Oct. 21, 2015—As part of its ongoing commitment to provide excellent care for heart failure patients in Tennessee and the Southeastern U.S., Vanderbilt Heart and Vascular Institute recently became the first medical center in the state to implant the HeartMate 3, a novel mechanical circulatory support device. Vanderbilt Heart is currently one of 60 select centers chosen...
Oct. 15, 2015—Ashish Shah, M.D., has joined Vanderbilt Heart and Vascular Institute (VHVI) as director of Heart Transplant and Mechanical Circulatory Support.
Oct. 15, 2015—Vanderbilt University Medical Center is hosting the first Global Cardio-Oncology Summit on Oct. 15-16, at the Hilton Nashville. The summit models a leading edge, interdisciplinary approach to cardio-oncology.
Oct. 8, 2015—The first study to suggest that major depressive disorder (MDD) is an independent risk factor for heart failure in HIV-positive adults has been published in Circulation.
Sep. 24, 2015—Vanderbilt is embarking on a multi-disciplinary approach to understand how promising cancer treatments, specifically certain kinase inhibitors, affect the heart and kidneys.
Sep. 17, 2015—The initial results of a landmark clinical trial sponsored by the National Institutes of Health (NIH) indicate lowering systolic blood pressure below a commonly recommended target significantly reduces rates of cardiovascular events and lowers risk of death in a group of adults 50 years and older.